Search clinical trials for: Xalacom Regulatory post marketing commitment plan safety

Total 110985 results

Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Long Term Use Of Xalacom In Patients Glaucoma Or Ocular Hypertension

Ocular Hypertension | Glaucoma
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Safety And Efficacy In Long Term Use Of Lyrica (Regulatory Post Marketing Commitment Plan) (RAINBOW-L)

Neuropathic Pain
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Safety And Efficacy Of Lyrica (Regulatory Post Marketing Commitment Plan) (RAINBOW)

Neuralgia
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Safety and Efficacy of Gabapen for Pediatric (Regulatory Post Marketing Commitment Plan)

Epilepsies, Partial
ViiV Healthcare
Pfizer

Completed

Safety And Efficacy Of Maraviroc In Patients For HIV Patients (Regulatory Post Marketing Commitment Plan)

CCR5-tropic HIV-1 Infection
Pfizer

Completed

Safety And Efficacy Of Crizotinib (Regulatory Post Marketing Commitment Plan)

Non-small Cell Lung Cancer
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Special Investigation of Pregabalin for Fibromyalgia (Regulatory Post Marketing Commitment Plan)

Pain Associated With Fibromyalgia
Pfizer

Completed

Long Term Use of Somavert (Pegvisomant) For A Regulatory Post Marketing Commitment Plan

Acromegaly
Pfizer

Completed

Special Investigation For Renal Cell Carcinoma (RCC) Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan)

Carcinoma, Renal Cell
Pfizer

Completed

Special Investigation For Gist Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan).

Gastrointestinal Stromal Tumors
Pfizer

Completed

Vyndaqel Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

Transthyretin Familial Amyloid Poluneuropathy
Pfizer

Completed

Tofacitinib (Xeljanz) Special Investigation for Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Pfizer

Completed

Diflucan Research For Infant Evaluation Of Antifungal Treatment And Prophylaxis Medication (DREAM)

Deep Mycosis
Pfizer

Completed

Drug Use Investigation for Toviaz

Overactive Bladder (OAB)
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Special Investigation For Long-Term Use Of Sildenafil (Regulatory Post Marketing Commitment Plan)

Pulmonary Hypertension
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

Hypertension | Angina Pectoris | Hypercholesterolemia | Familial Hypercholesterolemia
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Selara Drug Use Investigation (Regulatory Post Marketing Commitment Plan) (ESSENCE)

Hypertension
Pfizer

Completed

Viviant 20mg Special Investigation (Regulatory Post Marketing Commitment Plan) (VIOLINE)

Osteoporosis
Pfizer

Completed

BeneFIX Drug Use Results Survey [All-Case Surveillance]

Hemophilia B

Japan
Pfizer

Completed

Temsirolimus (Torisel) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

Renal Cell Carcinoma

Japan
Pfizer

Completed

Methotrexate (Rheumatrex) High Dose Special Investigation (Regulatory Post Marketing Commitment Plan)

Arthritis | Rheumatoid | High Dose

Japan
Pfizer

Completed

Special Investigation Of Azithromycin IV For Legionnaires' Disease (Regulatory Post Marketing Commitment Plan) (RESCUE-L)

Legionnaires' Disease | Legionella Pneumophila Infections
Pfizer

Completed

Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan) (RESCUE)

Pneumonia | Pelvic Inflammatory Disease
Pfizer

Completed

Etanercept (Enbrel) Special Investigation (Regulatory Post Marketing Commitment Plan)

Arthritis | Rheumatoid

Japan
Pfizer

Completed

Varenicline (Champix®) Special Investigation (Regulatory Post Marketing Commitment Plan)

Smoking Cessation
Pfizer

Completed

Drug Use Investigation Of Varenicline (Regulatory Post Marketing Commitment Plan)

Smoking Cessation
Pfizer

Completed

Voriconazole (Vfend) Special Investigation (Regulatory Post Marketing Commitment Plan)

Scedosporium Infection
Pfizer

Completed

Voriconazole (Vfend) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

Systemic Mycosis
Pfizer

Completed

Special Investigation For Long Term Use Of Tolterodine (Regulatory Post Marketing Commitment Plan).

Urinary Bladder, Overactive
Pfizer

Completed

Drug Use Investigation Of Zyvox (Linezolid) (Regulatory Post Marketing Commitment Plan)

Staphylococcal Infections
Pfizer

Completed

Zithromax-SR 2g, Special Investigation (Regulatory Post Marketing Commitment Plan)

Bacterial Infections
Novo Nordisk A/S

Not yet recruiting

Regulatory Post Marketing Surveillance (rPMS) Study of Rybelsus (Oral Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea

Diabetes Mellitus, Type 2
Novo Nordisk A/S

Not yet recruiting

Regulatory Post Marketing Surveillance (rPMS) Study of Ozempic (Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea

Diabetes Mellitus, Type 2
B. Braun Melsungen AG

Recruiting

Evaluation of Performance Over Dwell Time and Safety of the Central-venous Catheters Certofix® Paed

Central Venous Catheter

Germany, Italy
Novartis Pharmaceuticals

Recruiting

Study of Safety, Tolerability and Clinical Outcomes of Egaten in Fascioliasis Patients (6 Years of Age or Older).

Fascioliasis

Vietnam, Egypt, Colombia, Peru
Zhong Wang

Recruiting

Post-marketing Safety Surveillance of Xueshuantong-Injection : a Registry Study

Adverse Drug Event | Adverse Drug Reactions | Severe Adverse Reactions | Anaphylactic Reaction

China
Pfizer

Active, not recruiting

Korea Comirnaty Post-marketing Surveillance

COVID-19 | SARS-CoV-2 | Adverse Effects | Safety | Vaccines

Korea, Republic of
Bristol-Myers Squibb

Completed

A Study to Assess Safety of Nivolumab in Routine Oncology Practice in China

Non-Small Cell Lung Cancer | Squamous Cell Carcinoma of Head and Neck

China
Novo Nordisk A/S

Enrolling by invitation

Regulatory Post Marketing Surveillance (rPMS) Study of Xultophy® (Insulin Degludec/Liraglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea

Diabetes Mellitus, Type 2

Korea, Republic of
Jazz Pharmaceuticals

Completed

An Observational Post-Marketing Safety Registry of Sativex®

Multiple Sclerosis | Diabetes | Cancer | Neuropathic Pain
Novo Nordisk A/S

Completed

A Regulatory Post Marketing Surveillance (rPMS) Study of Ryzodeg® FlexTouch® (Insulin Degludec /Insulin Aspart) to Evaluate Safety and Effectiveness in Patients With Diabetes Mellitus in Routine Clinical Practice in Korea

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Korea, Republic of
Pfizer

Completed

Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis

Arthritis, Rheumatoid

Hong Kong, United States, Spain, Israel, Finland, Thailand, Turkey, Taiwan, Poland, Czechia, Malaysia, South Africa, Mexico, China, Australia, Slovakia, United Kingdom, New Zealand, Jordan, Canada, Netherlands, Brazil, Colombia, Puerto... and more
Novo Nordisk A/S

Completed

A Regulatory Post-marketing Surveillance (rPMS) Study to Evaluate the Safety and Effectiveness of Saxenda®(Liraglutide 3.0 mg) in Obese Patients and Overweight Patients With Obesity-related Comorbidities in Routine Clinical Practice in Korea.

Obesity | Overweight

Korea, Republic of
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox Capsule

Schizophrenia | Bipolar Disorder
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Tolterodine Drug Use Investigation.(Post Marketing Commitment Plan) (POTTOR)

Overactive Bladder
Pfizer
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From Remicade (PERSIST)

Rheumatoid Arthritis | Psoriatic Arthritis | Ankylosing Spondylitis | Rheumatoid Diseases

Spain, Canada, Greece, United Kingdom, Germany, Bulgaria, Czechia
Boehringer Ingelheim

Completed

A Regulatory Requirement Post-Marketing Surveillance Study to Monitor the Safety and Efficacy of Twynsta (Telmisartan + Amlodipine SPC, q.d.) in Korean Hypertensive Patients Requiring Combination Therapy

Hypertension

Korea, Republic of
Merck KGaA, Darmstadt, Germany
Merck Ltd., India

Terminated

A Post Marketing Surveillance Study to Assess the Safety and Efficacy of Cetuximab Plus Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck (PMS LAD SCCHN)

Unresectable Locally Advanced Squamous Cell Carcinoma of Head and Neck | LA SCCHN

India
Pfizer

Completed

Prevenar Special Use-result Surveillance in Japan (Regulatory PostMarketing Commitment Plan)

Streptococcus Pneumoniae | Pneumococcal Vaccine

Japan
Peking University Third Hospital
Peking University; Shanghai Greenvalley Pharmaceutical Co., Ltd.

Completed

Post-marketing Safety Surveillance of the Injection of DanShenDuoFenSuanYan A Real World Study

Adverse Drug Reaction

China

3

Subscribe